An Observational Trial: Patient Profile of Users of Secomet V®
Keywords:
Fulvic acid, HIV, CHD-FA, observational trial.
Abstract
Subsequent to a report published by Natasha Bolognesi in Nature Medicine in 20061 on a “herbal” product called Secomet V® researchers of the University of Pretoria undertook an observational trial to document the demographics, quality of life and disease profile of patients who purchase Secomet V®, a product that contains selenium, L-glutamin and high levels of a carbohydrate derived fulvic acid (CHD-FA). No traces of any plant extracts could be found in the product.
Published
2009-11-22
Section
Correspondence
By submitting manuscripts to SAFP, authors of original articles are assigning copyright to the South African Academy of Family Physicians. Copyright of review articles are assigned to the Publisher, Medpharm Publications (Pty) Ltd, unless otherwise specified. Authors may use their own work after publication without written permission, provided they acknowledge the original source. Individuals and academic institutions may freely copy and distribute articles published in SAFP for educational and research purposes without obtaining permission.